Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| SAKK | |||
| 21/00 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of the study is to assess the activity of fulvestrant in postmenopausal women with advanced breast cancer failing treatment with non-steroidal or steroidal aromatase inhibitors by estimating the Clinical Benefit Rate
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fulvestrant | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Benefit Rate |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of clinical benefit | ||
| Time to progression | ||
| Duration of response |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| AstraZeneca Switzerland Medical Director, MD | AstraZeneca | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Leuven | Belgium | ||||
| Research Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Time to treatment failure |
| Safety and tolerability |
| 6. clinical benefit rate according to HER2/neu status |
| Aarau |
| Switzerland |
| Research Site | Bern | Switzerland |
| Research Site | Geneva | Switzerland |
| Research Site | Lausanne | Switzerland |
| Research Site | Mendrisio | Switzerland |
| Research Site | Milano | Switzerland |
| Research Site | Sankt Gallen | Switzerland |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077267 | Fulvestrant |
| ID | Term |
|---|---|
| D004958 | Estradiol |
| D004963 | Estrenes |
| D004962 | Estranes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D045166 | Estradiol Congeners |
| D012739 | Gonadal Steroid Hormones |
| D042341 | Gonadal Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
Not provided
Not provided